Twist Bioscience officer proposes $563K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) officer Dennis H. Cho filed a notice covering the proposed sale of 5,427 common shares, with an aggregate market value of $562,716.95 and an approximate sale date of November 16, 2026. The shares were acquired from the issuer through restricted-stock vesting on November 12, 2026, as compensation.
The notice says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. It lists 62,707,424 shares outstanding and six sales by Cho from August 19 through November 3, including 14,205 shares on August 19 and 9,514 shares on October 2.
Key Figures
Key Terms
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior TWST sales does Dennis H. Cho list?
AI-generated analysis. How Rhea-AI works. Not financial advice.